Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression

Name: Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression
Published: 2025
License: Public Domain

Tel-Aviv Sourasky Medical Center · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

ovarian-cancer

ovarian cancer, ovarian cancer metastatic recurrent, perioperative intervention, beta-blockers, propranolol, cox-2 inhibitors, etodolac, psychoneuroimmunology, stress and cancer, randomized controlled trial (rct), biomarker analysis, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression

Related documents